10 months ago
BCRX
AnalystsStacy KuStacy Ku's Stock Forecasts
AnalystsStacy Ku
Sectors:
Analyst Ranking
Bottom 18%
#4390 out of 5337 analysts
Average Return
-5.96%
Win Rate
29%2 out of 7
Risk vs Reward
Poor
Good
Stacy Ku's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kalvista Pharmaceuticals IncKALV | +79.79% | $8.76 | $15.75 | 2025-01-07 - 2026-01-06 | Strong Buy |
Biocryst Pharmaceuticals IncBCRX | +39.94% | $6.81 | $9.53 | 2025-10-15 - 2026-07-29 | Strong Buy |
Stacy Ku Analyst Color
Get additional color on Stacy Ku's coverage of popular stocks
Stacy Ku's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tonix Pharmaceuticals Holding CorpTNXP | 1 | Strong Buy | $22.00 | +131.34% | Initiates Coverage On | 3 months ago |
Grace Therapeutics IncGRCE | 1 | Strong Buy | $8.00 | +284.62% | Maintains | 3 months ago |
Supernus Pharmaceuticals IncSUPN | 1 | Strong Buy | $60.00 | +28.84% | Maintains | 9 months ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Strong Buy | $30.00 | +214.80% | Reinstates | 10 months ago |
Kalvista Pharmaceuticals IncKALV | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Verrica Pharmaceuticals IncVRCA | 1 | Strong Buy | $100.00 | N/A | Maintains | 2 years ago |
Astria Therapeutics IncATXS | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.